Literature DB >> 17112740

Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.

Simone Appenzeller1, Leonardo Bonilha, Pablo A Rio, Li Min Li, Lilan Tereza Lavras Costallat, Fernando Cendes.   

Abstract

Cerebral atrophy has been described to occur in systemic lupus erythematosus (SLE) with variable frequency. The aim of this study was to determine white and gray matter abnormalities in brain magnetic resonance imaging (MRI) of patients with SLE and to determine if these abnormalities progress over a one-year period. Seventy-five patients with SLE and 44 healthy age and sex-matched controls were enrolled in this study. T1-weighted volumetric images were used for voxel based morphometry (VBM) analyses. SLE patients exhibited a significant reduction in white matter and gray matter volume compared to controls (p=0.001). Follow-up images, after an average interval of 19 months, revealed a progressive white matter and gray matter atrophy (p=0.001). Reduced white and gray matter volume was associated with disease duration and the presence of antiphospholipid antibodies. Patients with severe cognitive impairment had a more pronounced white and gray matter reduction than patients with moderate cognitive impairment. Total corticosteroid dose was associated with gray matter reduction and not with white matter loss in SLE patients. We concluded that brain tissue loss associated with SLE is significant and progresses over a relatively short period of time. Disease duration, the presence of antiphospholipid antibodies and cognitive impairment were associated with white and gray matter loss. Corticosteroid was associated only with gray matter atrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112740     DOI: 10.1016/j.neuroimage.2006.09.029

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  42 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration.

Authors:  Meggan Mackay; Mathew P Bussa; Cynthia Aranow; Aziz M Uluğ; Bruce T Volpe; Patricio T Huerta; Miklos Argyelan; Arthur Mandel; Joy Hirsch; Betty Diamond; David Eidelberg
Journal:  Mol Med       Date:  2011-09-21       Impact factor: 6.354

Review 3.  Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.

Authors:  Aida Zarfeshani; Kaitlin R Carroll; Bruce T Volpe; Betty Diamond
Journal:  Curr Rheumatol Rep       Date:  2021-03-29       Impact factor: 4.592

4.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

5.  Depression with psychotic features in a child with SLE: successful therapy with psychotropic medications--case report.

Authors:  Milica Pejovic Milovancevic; Vladimir Miletic; Smiljka Popovic Deusic; Saveta Draganic Gajic; Dusica Lecic Tosevski
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-10       Impact factor: 4.785

6.  Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus.

Authors:  Yun Lin; Qing-Hua Zou; Jian Wang; Yong Wang; Dai-Quan Zhou; Rong-Hua Zhang; Yan-Wei Zhang; Hai-Tao Lii; Yong-Fei Fang
Journal:  Hum Brain Mapp       Date:  2010-12-17       Impact factor: 5.038

7.  Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution.

Authors:  E Muscal; D R Bloom; J V Hunter; B L Myones
Journal:  Lupus       Date:  2009-12-21       Impact factor: 2.911

8.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

9.  Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Judith M Segall; Rachael G Grazioplene; Clifford Qualls; Wilmer L Sibbitt; Carlos A Roldan
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 10.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.